This content is machine translated Diabetic nephropathy Dapagliflozin and pioglitazone are not inferior as lone fighters The treatment of diabetic nephropathy (DN) has made significant progress in the past. Nevertheless, the number of diabetic patients who ultimately develop end-stage renal disease remains high. A combination of…
View Post 3 min This content is machine translated Epilepsy What to do if the therapy does not work? Around 60 million people worldwide are affected by epilepsy, the third most common neurological disorder. Up to 70% of patients can be effectively helped with initial therapy management and their…
View Post 5 min This content is machine translated Endometrial carcinoma Patients in advanced stages benefit from combination therapy Treatment management for patients with primarily advanced or recurrent endometrial cancer is changing. The potential of dostarlimab, which is particularly effective in patients with mismatch repair deficiency/high microsatellite instability, offers…
View Post 5 min This content is machine translated Endometrial Cancer Dostarlimab in everyday clinical practice: initial experiences with diagnostics and therapy Patients with primary advanced or recurrent endometrial cancer have a poor prognosis, particularly in the long-term course of treatment with carboplatin plus paclitaxel. This can be significantly improved with the…
View Post 3 min This content is machine translated Endometrial Cancer Prolonged progression-free survival through combination therapy Endometrial cancer is the sixth most common cancer in women worldwide and has a poor prognosis, particularly in terms of long-term results. The median overall survival time is less than…
View Post 4 min This content is machine translated Hypothyroidism L-thyroxine monotherapy is still considered the standard of care Patients with elevated TSH values should be evaluated for possible hypothyroidism, taking into account the respective reference standard value ranges and intra- and interindividual variability. In patients with hypothyroidism requiring…
View Post 2 min This content is machine translated Chronic renal failure in nondiabetic patients Additive benefit of combination therapy with modern active substances The burden of complications of chronic kidney disease (CKD) can be reduced by giving patients RAAS inhibitors combined with SGLT2 inhibitors. This is shown by research recently published in the…
View Post 1 min This content is machine translated Advanced bladder cancer Prolonged progression-free survival with combination therapy Preliminary study results suggest that the addition of immunotherapy to conventional chemotherapy may improve progression-free survival in patients with advanced bladder cancer. Is a paradigm shift on the horizon?
View Post 3 min This content is machine translated Hypertension Management Optimized blood pressure setting in everyday practice High blood pressure is still one of the leading causes of death. Despite good diagnostic possibilities, a large proportion of hypertension patients are not well controlled. That has to change.
View Post 6 min This content is machine translated Epilepsy Update anticonvulsants What has happened in drug therapy for epilepsy in the last two years? Prof. Hamer from Erlangen provided information about this at the annual meeting of the German and Austrian…
View Post 5 min This content is machine translated Small cell and non-small cell lung cancer Rapid progress through immunotherapy and immunochemotherapy Immunotherapy is one of the milestones of cancer therapy. However, the selection of particularly suitable patients remains a major challenge for first-line use.
